CAR T Moving Forward
Recent scientific developments, real clinical practice changes, and what is in store for EU patients
Speaker
Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center
Moderator
Chadi Nabhan, MD, MBA, FACP
Aptitude Health
Look Inside This Report
Download a sample of this report and start discovering the insights.
Topics Covered in the Report
- Integration of CAR T therapy within the community
- CAR T therapy within the setting of acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), and multiple myeloma (MM)
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- A moderated roundtable discussion focusing on CAR T-cell therapy was held on August 25, 2019, in Washington, DC, US
- Disease state and data presentations were developed in conjunction with an expert from MD Anderson Cancer Center
- The group of advisors comprised 10 community oncologists from the Northeast, US
- Data collection was accomplished through use of audience response system questioning and moderated discussion
